Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 22 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

18%

4 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (12)
Early P 1 (2)
P 3 (1)
P 4 (3)

Trial Status

Completed11
Unknown6
Recruiting4
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT01868087Early Phase 1Completed

Impact Advanced Recovery® for Radical Cystectomy (RC) Patients: a Pilot Study

NCT02908061Phase 3CompletedPrimary

A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia

NCT06190197Early Phase 1Recruiting

Prophylactic Antibiotics in Cystectomy With Diversion

NCT05714826Not ApplicableRecruiting

Comprehensive Optimization At-time of Radical Cystectomy Intervention

NCT03806439Not Yet Recruiting

Post-surgical Delirium in Patients Undergoing Radical Cystectomy.

NCT06783855Not ApplicableRecruitingPrimary

Outcomes of Uretheroileal Suspension Technique During Open Radical Cystectomy

NCT05578898Not ApplicableCompleted

CLEAR Care Companion Application

NCT06422182Not ApplicableCompleted

Erector Spinae Plane Block in Radical Cystectomy

NCT03305627Not ApplicableCompletedPrimary

Optimized Perioperative Antibiotic Prophylaxis in Radical Cystectomy

NCT05048199Not ApplicableCompletedPrimary

Hemodynamic Effects of Pressure-regulated Volume Control Mode in Patients With Diastolic Dysfunction Undergoing Radical Cystectomy

NCT06170177Recruiting

Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy

NCT05723991Phase 4UnknownPrimary

Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma

NCT03505112Not ApplicableCompleted

The Effect of Goal-directed Hemodynamic Therapy in Radical Cystectomy

NCT05097404UnknownPrimary

Clinical Utility of VI-RADS in Diagnosis of MIBC

NCT04687254Unknown

Gender-related Characteristics of Bladder Cancer Treatment

NCT03262480Not ApplicableCompletedPrimary

The Stroke Volume Optimization of Goal Directed Fluid Therapy During Radical Cystectomy

NCT03265470Not ApplicableCompletedPrimary

Renal Protection of Intravenous Dexmedetomidine During Radical Cystectomy

NCT01273987Not ApplicableCompleted

Neobladder Posterior Wall Suspended With Round Ligament of Uterus

NCT04152720Not ApplicableUnknown

Evaluate the Efficacy and Safety of Prevention of Infection Foley Catheter as Compared to Conventional Foley Catheter

NCT03147586Phase 4Unknown

Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy

Scroll to load more

Research Network

Activity Timeline